STING Contributes to Cancer-Induced Bone Pain by Promoting M1 Polarization of Microglia in the Medial Prefrontal Cortex.
Xiaoxuan ZhangXin LiWei WangYuxin ZhangZhihao GongYuan PengJingxiang WuXingji YouPublished in: Cancers (2022)
The medial prefrontal cortex (mPFC) is the main cortical area for processing both sensory and affective aspects of pain. Recently, mPFC was reported to participate in cancer-induced bone pain (CIBP) via the mechanism of central inflammation. STING is a key component of neuroinflammation in the central neuron system by activating downstream TBK1 and NF-κB signaling pathways. We aimed to investigate whether STING regulated neuroinflammation in the mPFC in rat models of CIBP. It is worth noting that we found a significant upregulation of STING in the mPFC after CIBP, accompanied by activation of TBK1 and NF-κB signaling pathways. In addition, pain and anxiety-like behaviors were alleviated by intraperitoneal injection of the STING inhibitor C-176. Furthermore, in microglia GMI-R1 cells, C-176 reversed LPS-induced M1 polarization. Collectively, this evidence indicated that STING may contribute to cancer-induced bone pain by activating TBK1 and NF-κB, and by promoting M1 polarization of microglia in the mPFC.
Keyphrases
- lps induced
- signaling pathway
- inflammatory response
- neuropathic pain
- chronic pain
- prefrontal cortex
- pain management
- induced apoptosis
- oxidative stress
- papillary thyroid
- pi k akt
- diabetic rats
- high glucose
- lipopolysaccharide induced
- bone mineral density
- spinal cord
- drug induced
- epithelial mesenchymal transition
- traumatic brain injury
- transcription factor
- toll like receptor
- bipolar disorder
- cognitive impairment
- cell proliferation
- depressive symptoms
- endothelial cells
- bone loss
- physical activity